Ausdal Financial Partners’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-6,683
| Closed | -$409K | – | 486 |
|
2021
Q4 | $409K | Sell |
6,683
-2,294
| -26% | -$140K | 0.05% | 319 |
|
2021
Q3 | $671K | Sell |
8,977
-19,658
| -69% | -$1.47M | 0.1% | 229 |
|
2021
Q2 | $2.65M | Buy |
28,635
+10,669
| +59% | +$987K | 0.4% | 76 |
|
2021
Q1 | $1.59M | Sell |
17,966
-13,274
| -42% | -$1.18M | 0.27% | 111 |
|
2020
Q4 | $2.91M | Buy |
31,240
+27,321
| +697% | +$2.55M | 0.57% | 49 |
|
2020
Q3 | $250K | Buy |
+3,919
| New | +$250K | 0.06% | 292 |
|